CDX-011

Key FDA Decisions and Trial Results Expected in October
24/7 Wall St
Tue, 10/4/16 - 10:07 am
FDA
clinical trials
Exelixis
cabozantinib
Cobimetinib
Celldex Therapeutics
CDX-011
Cerulean Pharma
CRLX101
Medivation
Xtandi
Palatin
bermelanotide
Rexahn
RX-3117
Anthera Pharmaceuticals
5 Companies Developing New Cancer Drugs
Yahoo/Benzinga
Tue, 08/19/14 - 04:40 pm
cancer
OncoSec
ImmunoCellular
CDX-011
Celldex Therapeutics
DCVax-L
Northwest Biotherapeutics
Inovio
3 Things to Watch With Celldex Therapeutics
Motley Fool
Thu, 10/4/12 - 10:52 am
Celldex
rindopepimut
CDX-011
Pfizer
Bristol-Myers Squibb
Amgen
Seattle Genetics